Bioteque (ROCO:4107) E10: NT$7.51 (As of Dec. 2025)


ROCO:4107 Bioteque Corp ROCO:4107
84 GF Score
Price NT$116.50
GF Value NT$129.03
Valuation Modestly Undervalued
View Full Analysis

What is Bioteque E10?

Bioteque ROCO:4107 +0.87% 84 E10 is NT$7.51 as of Dec. 2025. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$129.03 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bioteque's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$2.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$7.51 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Bioteque's average E10 Growth Rate was 5.60% per year. During the past 3 years, the average E10 Growth Rate was 7.20% per year. During the past 5 years, the average E10 Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bioteque was 14.70% per year. The lowest was 7.20% per year. And the median was 13.20% per year.

As of today (2026-07-04), Bioteque's current stock price is NT$116.50. Bioteque's E10 for the quarter that ended in Dec. 2025 was NT$7.51. Bioteque's Shiller PE Ratio of today is 15.51.

During the past 13 years, the highest Shiller PE Ratio of Bioteque was 37.94. The lowest was 14.88. And the median was 19.25.


Bioteque  (ROCO:4107) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bioteque's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=116.50/7.51
=15.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bioteque was 37.94. The lowest was 14.88. And the median was 19.25.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bioteque E10 Related Terms


Bioteque E10 Historical Data

* Premium members only.

The historical data trend for Bioteque's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioteque E10 Chart

Bioteque Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.31 6.09 6.60 7.11 7.51

Bioteque Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.11 7.28 7.39 7.44 7.51

ROCO:4107 vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Bioteque's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioteque Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bioteque's Shiller PE Ratio falls into.


ROCO:4107
84GF Score
Bioteque Corp ROCO:4107
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioteque E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioteque's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=2.23/324.0540*324.0540
=2.230

Current CPI (Dec. 2025) = 324.0540.

Bioteque Quarterly Data

per share eps CPI Adj_EPS
201603 1.310 238.132 1.783
201606 1.450 241.018 1.950
201609 1.160 241.428 1.557
201612 1.210 241.432 1.624
201703 0.690 243.801 0.917
201706 1.030 244.955 1.363
201709 1.330 246.819 1.746
201712 1.320 246.524 1.735
201803 1.190 249.554 1.545
201806 1.630 251.989 2.096
201809 1.350 252.439 1.733
201812 1.640 251.233 2.115
201903 1.670 254.202 2.129
201906 1.890 256.143 2.391
201909 1.640 256.759 2.070
201912 1.480 256.974 1.866
202003 1.560 258.115 1.959
202006 1.560 257.797 1.961
202009 1.750 260.280 2.179
202012 2.160 260.474 2.687
202103 1.730 264.877 2.117
202106 1.310 271.696 1.562
202109 1.290 274.310 1.524
202112 1.880 278.802 2.185
202203 1.750 287.504 1.972
202206 1.790 296.311 1.958
202209 1.930 296.808 2.107
202212 1.630 296.797 1.780
202303 1.420 301.836 1.525
202306 1.480 305.109 1.572
202309 2.100 307.789 2.211
202312 1.510 306.746 1.595
202403 1.810 312.332 1.878
202406 1.790 314.175 1.846
202409 2.070 315.301 2.127
202412 1.930 315.605 1.982
202503 1.930 319.799 1.956
202506 1.620 322.561 1.627
202509 1.970 324.800 1.965
202512 2.230 324.054 2.230

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$7.51 mean?
Bioteque (ROCO:4107) has a E10 of NT$7.51 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bioteque and its competitors.
Is Bioteque's E10 too high?
Bioteque's current E10 is NT$7.51. Overall, Bioteque has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's E10 compare to ISRG and BDX?
Bioteque's E10 of NT$7.51 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bioteque and its competitors. Bioteque's current E10 is NT$7.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.03, compared to a current price of NT$116.50 — trading 9.7% below its estimated fair value. The current E10 is NT$7.51. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current E10 is NT$7.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioteque (ROCO:4107) Overvalued in 2026?

Based on GuruFocus' analysis, Bioteque stock appears to be undervalued. The current stock price of NT$116.50 is trading 9.7% below its estimated GF Value™ of NT$129.03. GuruFocus considers Bioteque to be Modestly Undervalued.

Key valuation signals for ROCO:4107:

  • E10: NT$7.51
  • GF Value™: NT$129.03 vs. price of NT$116.50 (9.7% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioteque Business Description

Address Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score

Get the complete analysis for ROCO:4107

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$116.50
Price
NT$129.03
GF Value